Oncology Treatments
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
144
NCT06525298
EIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors
Phase: Phase 1/2
Role: Lead Sponsor
Start: Sep 9, 2024
Completion: Dec 31, 2027
Loading map...